mechanism of glp 1 agonist Frontiers Current Insights, Advantages and Challenges
Description
The gastrointestinal adverse event profile of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes [abstract]
J., Ahmad N
de Souza AH, Tang J, Yadev AK, Saghafi ST, Kibbe CR, Linnemann AK, Merrins MJ, and Davis DB
Get Started May support blood sugar regulation and insulin sensitivity as part of a clinician-guided metabolic plan
[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Cortes TM, Vasquez L, Serra MC, Robbins R, Stepanenko A, Brown K, Barrus H, Campos A, Espinoza SE, Musi N
